We are live on ! Find out more
AYTU icon

AYTU BioPharma
AYTU

66 hedge funds and large institutions have $12.4M invested in AYTU BioPharma in 2020 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 9

308% more capital invested

Capital invested by funds: $3.02M → $12.4M (+$9.33M)

167% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 6

100% more funds holding

Funds holding: 33 → 66 (+33)

4.99% more ownership

Funds ownership: 2.22% → 7.21% (+5%)

Holders
66
Holders Change
+33
Holders Change %
+100%
% of All Funds
1.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
42
Increased
16
Reduced
6
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$5.53M
2
BlackRock
BlackRock
New York
+$1.63M
3
Jane Street
Jane Street
New York
+$441K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$430K
5
Northern Trust
Northern Trust
Illinois
+$425K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$368K
2
Renaissance Technologies
Renaissance Technologies
New York
-$363K
3
SCM
Soleus Capital Management
Connecticut
-$209K
4
SC
Searle & Co
Connecticut
-$199K
5
Citadel Advisors
Citadel Advisors
Florida
-$62K

AYTU Hedge Fund Activity: Q2 2020 in Review

66 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in AYTU BioPharma (AYTU) for Q2 2020, worth a combined $12.4M — up 308% from $3.02M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new AYTU positions and 9 closed out — a net gain of 33 holders — while 16 added to existing stakes and 6 trimmed.

The largest buyer was Vanguard Group, adding an estimated $5.53M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $368K sold.

  • 66 institutional investors held AYTU BioPharma (AYTU) as of Q2 2020, up from 33 in Q1 2020.
  • Funds reported $12.4M of AYTU BioPharma stock for Q2 2020, up 308% quarter-over-quarter.
  • 42 funds opened new AYTU BioPharma positions in Q2 2020 and 9 closed out, a net change of +33 holders.
  • The largest AYTU BioPharma buyer in Q2 2020 was Vanguard Group, an estimated $5.53M added.
  • The largest AYTU BioPharma seller in Q2 2020 was Susquehanna International Group, an estimated $368K sold.

Based on aggregated 13F filings for Q2 2020.